Therapeutic Expertise
Therapeutic Expertise
Focused Science, Global Reach
At Astrum, we combine global operational capabilities, deep scientific expertise, and one of Europe’s largest hospital-based Phase I units in Porto to deliver clinical trials that accelerate milestones for both emerging biotechs and global pharmaceutical companies.
Oncology & Hematology
Oncology and hematology are among Astrum’s most established areas of expertise, with a strong focus on Phase II–IV multinational programs. We have deep experience in complex study designs, biomarker integration, and patient recruitment in competitive therapeutic areas.
Expertise includes:
- Breast cancer
- Lung cancer
- Hematologic & lymphatic cancers
- Gastrointestinal cancers
- Genitourinary & reproductive cancers
- Other solid tumors
Neurology
Astrum brings expertise across neurological and central nervous system (CNS) disorders, where trial design, patient access, and endpoint evaluation are often highly complex.
Expertise includes:
- Neurodegenerative diseases (Alzheimer’s, Parkinson’s)
- Epilepsy, seizure disorders, movement disorders
- Mental health (depression and related conditions)
- Rare/orphan neurological and neuromuscular diseases
- Pain-related conditions
Immunology & Rheumatology
Astrum supports the development of therapies for autoimmune, inflammatory, and rheumatologic conditions, combining translational science with operational delivery to achieve reliable outcomes.
Expertise includes:
- Autoimmune & inflammatory disorders (RA, lupus, psoriasis, IBD)
- Rheumatologic conditions (osteoarthritis, ankylosing spondylitis, musculoskeletal disorders)
- Allergic and immunological conditions
Additional Therapeutic Experience
In addition to our core therapeutic expertise, Astrum has supported clinical trials across a diverse range of indications including infectious diseases, metabolic disorders, cardiovascular disease, dermatology, and rare diseases.
This breadth of exposure allows our teams to apply proven operational approaches, recruitment strategies, and safety processes across different indications while adapting to the specific requirements of each protocol. As a mid size CRO, Astrum combines therapeutic versatility with close collaboration, responsive project teams, and consistent delivery, enabling us to support sponsors with reliable execution and high quality outcomes across a wide range of clinical development programs.
Why Astrum
Therapeutic Depth
Deep expertise across key therapeutic areas, with the flexibility to support all indications.
Proven late-phase experience
Across Phases II–IV, including registrational programs
Global reach
Integrated clinical development across global programs
Global credibility
Inspected and audited by FDA, EMA, and ANVISA
Integrated model
End-to-end delivery from first-in-human through registrational and post-marketing studies
Agile partnership
Hands-on, flexible partnerships tailored to each program